DC Chemicals

All products / DC2071

ABR-215062 (Laquinimod)
CAT. NO. DC2071

ABR-215062 (Laquinimod)

Pack sizes and prices

Pack sizePrice
100 mg$300 USDRequest a quote →
250 mg$600 USDRequest a quote →
1 g$1,000 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Laquinimod is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC2071
Product nameABR-215062 (Laquinimod)
CAS248281-84-7
Molecular formulaC19H17ClN2O3
Molecular weight356.8029
Purity99%
SMILESClC1=C([H])C([H])=C([H])C2=C1C(=C(C(N(C1C([H])=C([H])C([H])=C([H])C=1[H])C([H])([H])C([H])([H])[H])=O)C(N2C([H])([H])[H])=O)O[H]

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — ABR-215062 (Laquinimod) (DC2071)

Source references

[1]. Schulze-Topphoff, Ulf., et al. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS One (2012), 7(3), e33797. [2]. Toubi E, et al. Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis. J Neuroimmunol. 2012 Oct 15;251(1-2):45-54. [3]. Brück W, et al. Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol. 2012 Sep;124(3):411-24.

Related research products